News
Cabozantinib improves overall survival in renal cell carcinoma
Key clinical point: Cabozantinib significantly improved overall survival, compared with everolimus in patients with renal cell carcinoma. Major...
News
Delaying surgery for 11 weeks after RCT does not increase pCR rates for rectal cancer
Key clinical point: Delaying surgery for 11 weeks after the end of radiochemotherapy does not improve pathologic complete response rates in...
News
Olanzapine helps prevent nausea in patients on chemo
Key clinical point: Olanzapine significantly reduced episodes of nausea, compared with placebo. Major finding: The proportion of patients who...
News
No difference between chemo regimens for ovarian clear cell carcinoma
Key clinical point: Irinotecan plus cisplatin is no better than paclitaxel plus carboplatin for women with ovarian clear cell carcinoma Major...
News
Lack of hematology-specific measures not barrier to quality end of life care
Key clinical point: Standard measures are acceptable indicators of good quality end of life care for patients with hematologic malignancies. Major...
News
Pediatric cancer survivors at increased risk for endocrine abnormalities
Key clinical point: Survivors of pediatric-onset cancer are at increased risk for developing endocrine abnormalities. Major finding: Overall, 44%...
News
Pediatric Cancer Survivors at Increased Risk for Endocrine Abnormalities
Key clinical point: Survivors of pediatric-onset cancer are at increased risk for developing endocrine abnormalities. Major finding: Overall, 44...
News
Cisplatin-based chemo may be linked to hearing loss
Key clinical point: In male patients with adult-onset germ cell tumors, cisplatin-based chemotherapy may be associated with hearing loss. Major...
News
Early results positive for nivolumab as first-line therapy in advanced NSCLC
Key clinical point: A phase I trial indicates that nivolumab is safe and shows durable activity as a first-line therapy in treating patients with...
News
Nivolumab plus chemo shows increased response, decreased safety in NSCLC
Key clinical point: Nivolumab administered in combination with platinum-based doublet chemotherapy may improve response rates. However, the...
News
Racial bias linked with shorter, less-supportive appointments with black patients
Key clinical point: Higher implicit racial bias among oncologists was linked with less-supportive care for black patients. Major finding: Higher...